{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/STOK/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T17:54:40.802Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9585,"canonical_name":"Stoke Therapeutics, Inc.","cik":"0001623526","uei":null,"lei":null,"duns":null,"ticker":"STOK"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":42},"count":42,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — Stoke Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001623526/144/0001950047-26-010004","accession_number":"0001950047-26-010004","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001623526/4/0001780088-26-000023","accession_number":"0001780088-26-000023","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-10-02","url_slug":"/sec/cik-0001623526/4/0001966716-26-000014","accession_number":"0001966716-26-000014","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Stoke Therapeutics, Inc. — 2026-09-30","url_slug":"/sec/cik-0001623526/schedule-13g/0000921895-26-002685","accession_number":"0000921895-26-002685","importance":55},{"ts":"2026-09-25","kind":"sec.filing","form_type":"8-K","title":"8-K — Stoke Therapeutics, Inc. — 2026-09-25","url_slug":"/sec/cik-0001623526/8-k/0001193125-26-402820","accession_number":"0001193125-26-402820","importance":35},{"ts":"2026-09-25","kind":"sec.filing","form_type":"3","title":"3 — Stoke Therapeutics, Inc. — 2026-09-25","url_slug":"/sec/cik-0001623526/3/0001685994-26-000007","accession_number":"0001685994-26-000007","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-09-25","url_slug":"/sec/cik-0001623526/4/0001685994-26-000009","accession_number":"0001685994-26-000009","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-09-03","url_slug":"/sec/cik-0001623526/4/0001780088-26-000021","accession_number":"0001780088-26-000021","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-08-18","url_slug":"/sec/cik-0001623526/4/0001780088-26-000019","accession_number":"0001780088-26-000019","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-08-18","url_slug":"/sec/cik-0001623526/4/0001966716-26-000012","accession_number":"0001966716-26-000012","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Stoke Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001623526/schedule-13g-a/0000902664-26-003525","accession_number":"0000902664-26-003525","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Stoke Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001623526/schedule-13g-a/0000947263-26-000071","accession_number":"0000947263-26-000071","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Stoke Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001623526/schedule-13g-a/0000315066-26-002141","accession_number":"0000315066-26-002141","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001623526/4/0001780088-26-000017","accession_number":"0001780088-26-000017","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Stoke Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001623526/10-q/0001193125-26-330557","accession_number":"0001193125-26-330557","importance":45},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Ticho Barry","title":"CHIEF MEDICAL OFFICER","shares":5907,"price_per_share":28.9501,"usd_value":171008,"security_title":"Common Stock","importance":35.1710082407},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Ticho Barry","title":"CHIEF MEDICAL OFFICER","shares":1269,"price_per_share":29.4539,"usd_value":37377,"security_title":"Common Stock","importance":35.0373769991},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Stoke Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001623526/8-k/0001193125-26-330537","accession_number":"0001193125-26-330537","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Stoke Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001623526/8-k/0001193125-26-330804","accession_number":"0001193125-26-330804","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Stoke Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001623526/144/0001950047-26-007565","accession_number":"0001950047-26-007565","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"424B5","title":"424B5 — Stoke Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001623526/424b5/0001193125-26-330792","accession_number":"0001193125-26-330792","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"S-8","title":"S-8 — Stoke Therapeutics, Inc. — 2026-08-03","url_slug":"/sec/cik-0001623526/s-8/0001193125-26-330706","accession_number":"0001193125-26-330706","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"3","title":"3 — Stoke Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001623526/3/0001858760-26-000007","accession_number":"0001858760-26-000007","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001623526/4/0001858760-26-000008","accession_number":"0001858760-26-000008","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-07-06","url_slug":"/sec/cik-0001623526/4/0001780088-26-000015","accession_number":"0001780088-26-000015","importance":30},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Ticho Barry","title":"CHIEF MEDICAL OFFICER","shares":6728,"price_per_share":32.615,"usd_value":219434,"security_title":"Common Stock","importance":35.21943372},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Ticho Barry","title":"CHIEF MEDICAL OFFICER","shares":500,"price_per_share":33.2678,"usd_value":16634,"security_title":"Common Stock","importance":35.0166339},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Stoke Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001623526/144/0001950047-26-006742","accession_number":"0001950047-26-006742","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Stoke Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001623526/8-k/0001193125-26-289409","accession_number":"0001193125-26-289409","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001623526/4/0001966716-26-000010","accession_number":"0001966716-26-000010","importance":30},{"ts":"2026-06-16","kind":"sec.form144","reporter":"JONATHAN D ALLAN","title":"Officer","shares":1457,"usd_value":43710,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001950047-26-006194","importance":40.008742},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Allan Jonathan","title":"GENERAL COUNSEL & CORP SEC","shares":1457,"price_per_share":29.95,"usd_value":43637,"security_title":"Common Stock","importance":35.04363715},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Stoke Therapeutics, Inc. — 2026-06-16","url_slug":"/sec/cik-0001623526/144/0001950047-26-006194","accession_number":"0001950047-26-006194","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001623526/4/0001640069-26-000002","accession_number":"0001640069-26-000002","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-06-05","url_slug":"/sec/cik-0001623526/4/0001780081-26-000006","accession_number":"0001780081-26-000006","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Stoke Therapeutics, Inc. — 2026-06-04","url_slug":"/sec/cik-0001623526/8-k/0001193125-26-257394","accession_number":"0001193125-26-257394","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Stoke Therapeutics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001623526/4/0001780088-26-000013","accession_number":"0001780088-26-000013","importance":30},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Ticho Barry","title":"CHIEF MEDICAL OFFICER","shares":1795,"price_per_share":30.58,"usd_value":54891,"security_title":"Common Stock","importance":35.0548911},{"ts":"2026-05-18","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Stoke Therapeutics, Inc. — 2026-05-18","url_slug":"/sec/cik-0001623526/schedule-13g-a/0000902664-26-002559","accession_number":"0000902664-26-002559","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Stoke Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001623526/schedule-13g/0000902219-26-000132","accession_number":"0000902219-26-000132","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Stoke Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001623526/schedule-13g-a/0000902664-26-002530","accession_number":"0000902664-26-002530","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Stoke Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001623526/schedule-13g-a/0000947263-26-000048","accession_number":"0000947263-26-000048","importance":30}]}